Results 1 to 10 of about 41,304 (260)

Direct oral anticoagulant: Review article

Journal of Family Medicine and Primary Care, 2022
Venous thromboembolism (VTE) and atrial fibrillation (AF) is a major burden on the health care system. The average occurrence of venous thromboembolism annually is around 108 per 100,000 person-year.
Abdulrahman Nasiri, Ahmed AlQahtani, Nora H Rayes, Rawan AlQahtani, Reem Alkharras, Hamad Alghethber   +5 more
doaj   +3 more sources

Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The optimal antithrombotic strategies for patients with atrial fibrillation who experience ischemic stroke (IS) despite direct oral anticoagulant (DOAC) therapy remain inconclusive. This study compared outcomes for patients with DOAC treatment
Shin‐Yi Lin, Yun‐Tsz Liao, Sung‐Chun Tang, Ching‐Ching Claire Lin, Chi‐Chuan Wang   +4 more
doaj   +3 more sources

Direct oral anticoagulants uptake and an oral anticoagulation paradox [PDF]

British Journal of Clinical Pharmacology, 2020
Oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation is underutilised. One of the impediments to warfarin therapy is the frequent monitoring required, usually at a specialised warfarin clinic. The advent of direct oral anticoagulants (DOACs) facilitates OAC therapy without an onerous monitoring regimen. This benefit may
Cormac Kennedy, Caitriona Ni Choitir, Sarah Clarke, Kathleen Bennett, Michael Barry   +4 more
openaire   +2 more sources

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis

Tzu Chi Medical Journal, 2023
Objectives: Anticoagulants have been used as therapeutic or prophylactic agents in COVID-19 and seem to be more beneficial. However, the advantage of oral anticoagulant (OAC) consumption before visit in lowering mortality in COVID-19 patients remains ...
Cornelia Ghea, Ardyan Wardhana, Alfredo Nugroho, Fika Humaeda Assilmi   +3 more
doaj   +1 more source

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs

Российский кардиологический журнал, 2021
The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj   +1 more source

Direct oral anticoagulants (DOACs) [PDF]

Vascular Medicine, 2015
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects ...
Sara, Vazquez, Matthew T, Rondina
openaire   +2 more sources

Safety and differences between direct oral anticoagulants and vitamin K antagonists in the risk of post-traumatic intrathoracic bleeding after rib fractures in elderly patients

Emergency Care Journal, 2021
Closed chest traumas are frequent consequences of falls in the elderly. The presence of concomitant oral anticoagulant therapy can increase the risk of post-traumatic bleeding even in cases of trauma with non-severe dynamics. There is limited information
Gianni Turcato, Arian Zaboli, Andrea Tenci, Giorgio Ricci, Massimo Zannoni, Christoph Scheurer, Anton Wieser, Antonio Maccagnani, Antonio Bonora, Norbert Pfeifer   +9 more
doaj   +1 more source

DIRECT ORAL ANTICOAGULANTS

Obstetrics, Gynecology and Reproduction, 2016
Several direct oral anticoagulants (DOACs), namely, apixaban, rivaroxaban, and dabigatran etexilate, are currently licensed in Europe and the United States for various thromboembolic indications. They provide alternatives to low molecular weight heparin in a peri-operative setting for venous thromboembolism (VTE) prophylaxis and therapy and to vitamin ...
TZORAN INNA, BRENNER BENJAMIN
openaire   +4 more sources

Enhancement and evaluation of a prescription audit system for direct oral anticoagulants using a check sheet

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Renal function and use of concomitant medications should be carefully monitored in patients subjected to treatment with direct oral anticoagulants (DOACs); the dose should be individually designed for each patient.
Naoto Ishikawa, Hanae Oshikiri, Shinya Takasaki, Masafumi Kikuchi, Taku Obara, Kazutoshi Akasaka, Masaki Matsuura, Hiroaki Yamaguchi, Nariyasu Mano   +8 more
doaj   +1 more source

Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.

PLoS ONE, 2020
BACKGROUND:Warfarin is an anticoagulant medication proven effective in the initial treatment and secondary prevention of venous thromboembolism. Anti-Xa direct oral anticoagulants are alternatives to warfarin; however there is limited data assessing ...
Thomas Hendriks, Scott McGregor, Shilpa Rakesh, Julie Robinson, Kwok M Ho, Ross Baker   +5 more
doaj   +1 more source